Back to Journals

Biologics: Targets and Therapy

ISSN: 1177-5491


Professor Shein-Chung Chow

Professor Chow

Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC, USA

Shein-Chung Chow, Ph.D. is currently a Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA. Dr. Chow is also an Adjunct Professor at Peking University and Beijing Capital Medical University, Beijing, China. Dr. Chow was also a special government employee (SGE) appointed by the United States Food and Drug Administration (FDA) as an Oncologic Drug Advisory Committee (ODAC) voting member and Statistical Advisor to the FDA (2015-2017, 2019-2022). Between 2017-2019, Dr. Chow was on-leave for FDA as an Associate Director at Office of Biostatistics, Center for Drug Evaluation and Research (CDER), FDA. Dr. Chow was the Editor-in-Chief of the Journal of Biopharmaceutical Statistics (1992-2020) and is the Editor-in-Chief of the Biostatistics Book Series at Chapman and Hall/CRC Press of Taylor & Francis Group. He was elected Fellow of the American Statistical Association in 1995 and an elected member of the ISI (International Statistical Institute) in 1999.

Dr. Chow is the author or co-author of over 350 methodology papers and 33 books including Design and Analysis of Bioavailability and Bioequivalence Studies, Design and Analysis of Clinical Trials, Analytical Similarity Assessment in Biosimilar Drug Development, Advanced Statistics in Regulatory Critical Clinical Initiatives, and most recently, Innovative Methods for Rare Disease Drug Development.


Editorial Board

Melisa I. Barliana, Professor, Ph.D, Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia.

Dr Alida Benfante Department of Pneumology, University Hospital Policlinico Paolo Giaccone, Italy.

Dr Cho, Ph.D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, People's Republic of China.

Wei-Qun Ding, PhD, Professor of Experimental Pathology, Department of Pathology, University of Oklahoma Health Sciences Center, USA

Robert Eisenberg, Emeritus Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

Bithiah Grace Jaganathan, Dr, Associate Dean, Students' Affairs, Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, India.

Maher Kurdi, MD, FRCP (Canada), FRCPath, (UK), FEFN (EU), Clinical Associate Professor of Neuropathology and Neuromuscular Pathology. Chairman, Department of Pathology, Faculty of Medicine, Rabigh, King Abdulaziz University. Chief, Brain Tumour Research Group, King Fahad Medical Research Center, Kingdom of Saudi Arabia.

Cato T. Laurencin, University Professor; Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery; Professor of Chemical and Biomolecular Engineering; Professor of Materials Science and Engineering; Professor of Biomedical Engineering; Chief Executive Officer, The Cato T. Laurencin Institute for Regenerative Engineering, The University of Connecticut, Storrs, CT, USA

George C Prendergast, Professor & President/CEO, Lankenau Institute for Medical Research, USA

Ranjit Ranbhor, Scientific Advisor, Pergament & Cepeda LLP, New Jersey, USA.

Garry M. Walsh, Professor, Emeritus Reader in Inflammation & Immunity, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, U.K.

Shuyu Zhang, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu 610041, China.